Formosa Pharmaceuticals
Taiwan - Taipei
Pharmaceutical1 H-1B visas (FY2023)Focus: Activus Pure Nanoparticle Technology
Formosa Pharmaceuticals is a life sciences company focused on Activus Pure Nanoparticle Technology.
Neurology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
APP13007, 0.05%
Ocular Inflammation and Pain After Cataract SurgeryClinical Trials (1)
NCT04089735A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of APP13007 to Treat Inflammation and Pain After Cataract Surgery
Phase 2EX039
Alzheimer DiseaseClinical Trials (1)
NCT05413655A Study of Oral EX039 in Subjects with Mild Alzheimer's Disease
Phase 2APP13007, 0.05%
Ocular Inflammation and Pain After Cataract SurgeryClinical Trials (1)
NCT04810962Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery Including a Corneal Endothelial Cell Sub-study
Phase 3APP13007, 0.05%
Ocular Inflammation and PainClinical Trials (1)
NCT04739709Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 4 clinical trials
H-1B (2023): 1 approval
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub